1. There is no significant difference for perceived dyspnea in patients taking dexamethasone as compared to placebo. 2. Cancer patients ...
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
1. High dose dexamethasone was nonsuperior in regards to 60-day survival outcomes as compared with regular dose dexamethasone in COVID-19 ...
1. This multi-centered, randomized controlled trial demonstrated that 12 mg and 6 mg dexamethasone daily had similar efficacy for days ...
1. Time to recovery was lower in patients assigned to budesonide compared to usual care, meeting the superiority criteria. 2. ...
1. Daratumumab therapy addition to bortezomib, cyclophosphamide, and dexamethasone showed improved cancer response in patients with systemic immunoglobulin light-chain amyloidosis. ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.